{"id":"NCT00111007","sponsor":"Bayer","briefTitle":"A Treatment Combination for Patients With Unresectable Stage III or Stage IV Melanoma","officialTitle":"Phase III Randomized, Placebo Controlled Study of Sorafenib in Repeated Cycles of 21 Days in Combination With Paclitaxel/Carboplatin Chemotherapy in Subjects With Unresectable Stage III or Stage IV Melanoma.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-05","primaryCompletion":"2006-09","completion":"2009-01","firstPosted":"2005-05-17","resultsPosted":"2011-02-23","lastUpdate":"2014-10-31"},"enrollment":270,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Melanoma"],"interventions":[{"type":"DRUG","name":"Sorafenib (Nexavar, BAY43-9006)","otherNames":[]},{"type":"DRUG","name":"Carboplatin/Paclitaxel","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Sorafenib (Nexavar, BAY43-9006)","type":"EXPERIMENTAL"},{"label":"Carboplatin/Paclitaxel (C/P)","type":"ACTIVE_COMPARATOR"}],"summary":"The objectives of this study are to compare the anti-tumor activity as measured by Progression Free Survival (PFS) and tolerability of Sorafenib in combination with Paclitaxel and Carboplatin versus Paclitaxel and Carboplatin in combination with placebo in subjects with unresectable Stage III or Stage IV melanoma who progressed after receiving only one prior therapy containing Dacarbazine (DTIC) or Temozolomide (TMZ).","primaryOutcome":{"measure":"Progression Free Survival (PFS)","timeFrame":"Time from randomization to documented tumor progression or death (median time of 124 days)","effectByArm":[{"arm":"Sorafenib (Nexavar, BAY43-9006)","deltaMin":122,"sd":null},{"arm":"Carboplatin/Paclitaxel (C/P)","deltaMin":125,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.492"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":4},"locations":{"siteCount":66,"countries":["United States","Australia","Canada","France","Germany","Netherlands","United Kingdom"]},"refs":{"pmids":["19349552"],"seeAlso":["http://www.clinicaltrialsregister.eu"]},"adverseEventsSummary":{"seriousAny":{"events":66,"n":134},"commonTop":["fatigue","alopecia","neuropathy: sensory","nausea","neutrophils"]}}